| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $77.9M | +11.1% |
| SG&A Expense | $32.2M | +1.5% |
| Operating Income | -$110.1M | -8.1% |
| Pre-tax Income | -$95.6M | -7.9% |
| Income Tax | $581K | +123.5% |
| Net Income | -$96.2M | -8.3% |
| EPS (Basic) | -$1.03 | +8.0% |
| EPS (Diluted) | -$1.03 | +8.0% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $524.7M | +225.0% |
| Short-term Investments | $494.2M | +151.2% |
| Current Assets | $1.02B | +182.8% |
| Total Assets | $1.03B | +181.7% |
| Current Liabilities | $16.4M | +4.9% |
| Total Liabilities | $18.6M | +2.7% |
| Stockholders' Equity | $1.01B | +191.0% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$82.2M | -17.4% |
| Capital Expenditures | $0 | -100.0% |
| Investing Cash Flow | -$298.0M | -2301.6% |
| Financing Cash Flow | $743.5M | +353.4% |
| Free Cash Flow | -$82.2M | -17.3% |